Expedition Medicines
Cambridge
About Expedition Medicines
Expedition Medicine's industry-leading chemoproteomics data generating engine learns the rules of molecular reactivity, enabling programmable small molecule medication design.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 11 – 50
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2025)
- Website: expeditionmedicines.com
- Phone: [email protected]
Industries & Categories
Advanced Materials, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/expedition-medicines-37912 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.